Compare Capitalinc Investment Tbk. (MTFN) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Capitalinc Investment Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Capitalinc Investment Tbk. trades at Rp13 (market cap 413.95B, 21.34M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Capitalinc Investment Tbk. is far larger — about 4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MTFN | SCPI | |
|---|---|---|
Market Cap | 413.95B | 104.4B |
Volume | 21.34M | — |
Lot | 213.43K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Capitalinc Investment Tbk.
PT Capitalinc Investment Tbk formerly PT Bakrie Finance Corporation Tbk hereinafter called the Company was established based on deed No.15 dated November 11, 1993 of Notary Soedarno, SH. The deed of establishment was approved by the Minister of Justice of the Republic of Indonesia in his decree No. C2.7999-HT.01.01.Th.83 dated December 12, 1983 and was published in the State Gazette of the Republic of Indonesia No.4 dated January 13, 1984, Supplement No.35.Before the amendment in its articles of association, the scope of its activities include leasing, factoring receivable and consumer financing. The Company obtained its operating license as a financial institution from the Minister of Finance of the Republic of Indonesia through decree No.295/KMK.013/1990 dated March 3, 1990. In line with the change in the Company’s scope of activities, the Company’s financing activities have been transferred to PT Swadinamika Bakrie Finance, a subsidiary.
Read more on MTFN →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
